'Sh42b needed to commercialise anti-tick vaccine'

12th November 2024

Research and further development of the vaccine needs to be amplified to full production for commercial levels.

PREMIUM Agric. & Environment

Research and further development of the vaccine needs to be amplified to full production for commercial levels. (Courtesy)

NewVision Reporter

@NewVision

#Anti-tick vaccine #Makerere University

___________________

Authorities at Makerere University and Alfasan Uganda Ltd, a private pharma company, say they need at least sh42b to produce an anti-tick vaccine for commercialisation. Alfasan was

This is a premium article please Subscribe

Related Stories
Agric. & Environment
'Budget cuts will stifle anti-tick vaccine production'
Agric. & Environment
Research holds key to better farming, says Tumwebaze
Agric. & Environment
Uganda develops anti-tick vaccines to boost dairy, beef industry
Agric. & Environment
NARO prioritizes new crop variates in new financial year
Agric. & Environment
MPs want partnership to promote new agro technologies
Agric. & Environment
NARO’s innovative animal, crop varieties reshaping agriculture